Journal of Drug Discovery and Therapeutics http://jddt.in/index.php/jddt <p><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><span style="text-align: justify;"><strong>Journal of Drug Discovery and Therapeutics (JDDT)</strong> is an international, peer-reviewed, open access, online journal dedicated to the rapid publication of full-length original research papers, short communications, invited reviews, Case studies and editorial commentary and news, Opinions &amp; Perspectives and Book Reviews written at the invitation of the Editor in all areas of the Biomedical and Pharmaceutical Sciences.</span></span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Medical || Dentistry || Biomedical Sciences || Ayurveda || Homeopathy || </strong></span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;">Anatomy, Physiology, Biochemistry, Molecular Biology, Cell biology, Genetics, Hematology, Pathology, Immunology, Microbiology, Virology, Parasitology, Surgery, Dental Sciences, Sports Physiology, Histopathology, Toxicology and all major disciplines of Biomedical Sciences.<br /><strong>Pharmaceutical Sciences || Allied Sciences </strong></span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;">Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Pharmacology and Toxicology, Pharmaceutical and Biomedical Analysis, Clinical Research, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology and all major disciplines of Pharmaceutical Sciences.</span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;">Articles are published as they are accepted and are freely available on the journal’s website to facilitate rapid and broad dissemination of research findings to a global audience.</span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Top Reasons for publication with us</strong></span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Quick Quality Review:</strong> The journal has strong international team of editors and reviewers, Rapid Decision and Publication</span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Very Low Publication Fees:</strong> Comparable journals charge a huge sum for each accepted manuscript. JDDT only charge the fees necessary to recoup cost associated with running the journal</span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Other features:</strong> DIDS Assigned and Implemented the Open Review System (ORS).</span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>Important Notice:</strong></span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;">Author can now directly send their manuscript as an email attachment to</span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;">Innovative Library</span></span></p> <p style="text-align: justify;"><span style="font-family: lucida sans unicode,lucida grande,sans-serif;"><span style="font-size: 14px;"><strong>editor@jddt.in</strong>, <strong>editorjddt.in@gmail.com</strong></span></span></p> <p> </p> en-US editor@jddt.in (JDDT-PUBLISHER) INNOVATIVELIBRARY6@GMAIL.COM (INN. LIB) Mon, 11 Jan 2021 04:03:00 -0500 OJS 3.2.1.1 http://blogs.law.harvard.edu/tech/rss 60 Steriochemistry and validation of the structure of cyclooxygenase, preferred target of controversial non-steroidal anti-inflammatory drugs during the COVID 19 pandemic http://jddt.in/index.php/jddt/article/view/339 <p>During COVID-19 infection, the scarce published data on nonsteroidal anti-inflammatory drugs is very controversial. In the literature, several models of cyclooxygenase, their preferred target, have been identified. The aim is to study their sterochemistry and validate the best structure. PDB entries were viewed using Discovery Studio 2.5 software. MolProbity was used for steriochemical analysis. The structures of COX bound to Naproxen (3NT1: 1.73 Å) and Ibuprofen (4PH9: 1.81Å) are of higher resolution. In the Ramachandran diagram, for 4PHP and 3LN1, 100.0% of the residues were in allowed regions. For the Rlibre factor the values of (19.8%) for 4PH9, (20.0%) for 3NT1 and (22.4%) for 1CVU were within the expected ranges. They were rather high for 3LN1, 1PXX and 4COX. The clashscores for 3NT1 (99th percentile) and 4PH9 (98th percentile) were at the top of the best ranges. 4PH9 (sidechain outliers: 1.5%) and 3NT1 (sidechain outliers: 1.8%) were modeled with their preferred rotamers. By comparing all metrics, 4PH9 appears to be the finest crystal structure. PDB entries do not necessarily constitute a reliable source of steriochemistry. Our study made it possible to verify the adherence of the models to the structural principles established to guarantee their quality. This is an essential step in the design of structure-based drugs.</p> <p><strong>Keywords:</strong> Steriochemistry, validation, cyclooxygenase, non-steroidal anti-inflammatory drugs, COVID 19</p> Hamza Nadjib Merad-boudia, Majda Dali-Sahi, Nouria Dennouni-Medjati Copyright (c) 2021 http://jddt.in/index.php/jddt/article/view/339 Mon, 11 Jan 2021 00:00:00 -0500